Rafferty Asset Management
TNGX icon

Rafferty Asset Management’s Tango Therapeutics TNGX Stock Holding History

Rafferty Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Sell
80,141
-24,819
-24% -$614K 0.01% 588
2026
Q1 		$2.2M Sell
104,960
-121,641
-54% -$1.69M 0.01% 588
2025
Q4 		$2.01M Buy
226,601
+81,285
+56% +$700K 0.01% 646
2025
Q3 		$1.22M Buy
+145,316
New +$983K ﹤0.01% 751
2024
Q4 		– Sell
-102,955
Closed -$793K – 1174
2024
Q3 		$793K Buy
102,955
+30,066
+41% +$287K ﹤0.01% 846
2024
Q2 		$625K Sell
72,889
-147,130
-67% -$1.14M ﹤0.01% 902
2024
Q1 		$1.75M Buy
+220,019
New +$2.36M 0.01% 717

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Rafferty Asset Management's TNGX Position: Q2 2026 in Review

Rafferty Asset Management reduced its Tango Therapeutics (TNGX) stake by 24% in Q2 2026, selling an estimated $614K and leaving 80,141 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #588.

Rafferty Asset Management first reported a position in TNGX in Q1 2024 and has held it in 7 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Rafferty Asset Management held 80,141 shares of Tango Therapeutics worth $2.51M as of Q2 2026.
  • Rafferty Asset Management sold 24,819 Tango Therapeutics shares in Q2 2026, an estimated $614K.
  • Tango Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #588 holding.
  • Rafferty Asset Management first reported a position in Tango Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.